Report from the 19th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29–30 September 2017

Current oncology

B. Brunet¹  C. Doll²  C.A. Kim³  V. Gordon⁴  S. Ahmed⁵  H. Chalchal⁶  M.P. Dupre⁷  R. Deobald⁸ 

[1] Allan Blair Cancer Centre;BC Cancer, University of British Columbia;CancerCare Manitoba, University of Manitoba;Cross Cancer Institute, University of Alberta;Saskatchewan Cancer Agency, University of Saskatchewan;Tom Baker Cancer Centre, University of Calgary;University of British Columbia;University of Manitoba

关键词: Colorectal cancer;    adjuvant chemotherapy;    surgery;    molecular tests;    immunotherapy;    radioembolization;    sidedness;   

DOI  :  10.3747/co.25.4109

学科分类：肿瘤学

来源: Multimed, Inc.

【 摘 要 】

The 19th annual Western Canadian Gastrointestinal Cancer Consensus Conference (wcgccc) was held in Winnipeg, Manitoba, 29–30 September 2017. The wcgccc is an interactive multidisciplinary conference attended by health care professionals from across Western Canada (British Columbia, Alberta, Saskatchewan, and Manitoba) who are involved in the care of patients with gastrointestinal cancer. Surgical, medical, and radiation oncologists; pathologists; radiologists; and allied health care professionals participated in presentation and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses current issues in the management of colorectal cancer.

【 授权许可】

Unknown